Atlas Trials

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Clinical trial NCT00520533 · TERMINATED

Trial details

NCT number
NCT00520533
Sponsor
Ludwig Institute for Cancer Research
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell Carcinoma (RCC)
Start date
2008-02-01
Primary completion
2011-07-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.